Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beam Therapeutics Inc. Director's Dealing 2021

Jan 4, 2021

31533_dirs_2021-01-04_163f2900-43e9-4684-8a18-7b4197fcaad8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2020-12-30

Reporting Person: Ciaramella Giuseppe (President & CSO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-30 Common Stock M 43842 $1.03 Acquired 47573 Direct
2020-12-30 Common Stock S 2299 $79.03 Disposed 45274 Direct
2020-12-30 Common Stock S 3510 $80.12 Disposed 41764 Direct
2020-12-30 Common Stock S 8809 $80.97 Disposed 32955 Direct
2020-12-30 Common Stock S 5297 $82.00 Disposed 27658 Direct
2020-12-30 Common Stock S 2805 $83.12 Disposed 24853 Direct
2020-12-30 Common Stock S 8248 $84.06 Disposed 16605 Direct
2020-12-30 Common Stock S 3049 $85.16 Disposed 13556 Direct
2020-12-30 Common Stock S 6756 $86.27 Disposed 6800 Direct
2020-12-30 Common Stock S 769 $86.96 Disposed 6031 Direct
2020-12-30 Common Stock S 1700 $88.22 Disposed 4331 Direct
2020-12-30 Common Stock S 600 $89.66 Disposed 3731 Direct
2020-12-30 Common Stock M 12000 $0.67 Acquired 15731 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-30 Stock Option (Right to Buy) $1.03 M 43842 Disposed 2028-07-13 Common Stock (43842) Direct
2020-12-30 Stock Option (Right to Buy) $0.67 M 12000 Disposed 2028-05-08 Common Stock (12000) Direct

Footnotes

F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: 25% of the shares subject to the stock option vested on the first anniversary of the of the vesting commencement date, February 26, 2018, and the remaining shares shall vest in 36 substantially equal monthly installments thereafter, subject to continued service with BEAM through such dates.

F3: These shares were sold in multiple transactions ranging from $78.49 to $79.48 inclusive.

F4: These shares were sold in multiple transactions ranging from $79.52 to $80.51 inclusive.

F5: These shares were sold in multiple transactions ranging from $80.52 to $81.51 inclusive.

F6: These shares were sold in multiple transactions ranging from $81.52 to $82.51 inclusive.

F7: These shares were sold in multiple transactions ranging from $82.52 to $83.51 inclusive.

F8: These shares were sold in multiple transactions ranging from $83.60 to $84.59 inclusive.

F9: These shares were sold in multiple transactions ranging from $84.69 to $85.68 inclusive.

F10: These shares were sold in multiple transactions ranging from $85.71 to $86.69 inclusive.

F11: These shares were sold in multiple transactions ranging from $86.72 to $87.51 inclusive.

F12: These shares were sold in multiple transactions ranging from $87.80 to $88.67 inclusive.

F13: These shares were sold in multiple transactions ranging from $89.66 to $89.67 inclusive.